What question did this study set out to answer?

To describe the global clinical challenge of drug-resistant tuberculosis and outline the advisory role of the ERS/WHO Consilium in supporting clinicians managing complex cases.

February 28, 2013European Respiratory JournalOpen Access

Supporting TB clinicians managing difficult cases: the ERS/WHO Consilium

View Full Paper

Ask AI

Bookmark

Authors

FBFrancesco BlasiUniversity of Insubria MDMasoud DaraNovel (Germany)MWMarieke J. van der WerfEuropean Centre for Disease Prevention and Control

Discussion

Member takes

Implication

Clinical overview highlights expert advisory support in patients with drug-resistant tuberculosis, indicating collaborative international initiatives to counter alarming resistance rates.

Key Points

To describe the global clinical challenge of drug-resistant tuberculosis and outline the advisory role of the ERS/WHO Consilium in supporting clinicians managing complex cases.
Characterized definitions of multidrug-resistant tuberculosis (resistance to isoniazid and rifampicin) and extensively drug-resistant tuberculosis (additional resistance to fluoroquinolones and injectable second-line agents).
Evaluated public health concerns regarding escalating resistance rates across Eastern Europe and globally to determine clinician support needs.
Identified alarming international increases in multidrug-resistant and extensively drug-resistant tuberculosis cases, prompting major concern from health authorities and professional societies.
Established the clinical necessity for centralized expert consultation platforms to assist healthcare providers in navigating complex second-line regimens and adverse drug profiles.

Cite This Study

Blasi et al. (2013) studied this question.

synapsesocial.com/papers/6a8aa50caf6b08ee8d72489d https://doi.org/10.1183/09031936.00196712

View Full Paper

Ask AI

Bookmark

Implication

Clinical overview highlights expert advisory support in patients with drug-resistant tuberculosis, indicating collaborative international initiatives to counter alarming resistance rates.

Supporting TB clinicians managing difficult cases: the ERS/WHO Consilium

Discussion

Member takes

Implication

Key Points

Cite This Study

Supporting TB clinicians managing difficult cases: the ERS/WHO Consilium

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider